WASHINGTON (Reuters) --- Malaria rates are climbing in poor countries that have stopped using the pesticide DDT to control the deadly disease, a tropical diseases expert warned on Tuesday.
Donald Roberts, speaking for a coalition that is promoting DDT as a means of controlling malaria in developing countries, said the chemical was safe if sprayed in small amounts inside homes to repel mosquitoes that carry the parasite which causes malaria.
For many poor nations, DDT is the only affordable way to try to reduce the 500 million malaria infections each year, Roberts said. About 2.5 million people die from malaria annually.
Roberts said malaria was on the rise in Brazil, throughout Africa and elsewhere. For example, malaria rates increased 12 times in Guyana from 1984 to 1991 after DDT spraying was reduced, he said.
But industrialized nations and environmental groups have pressured developing countries to stop using DDT. Many countries banned it in the 1970s after it was linked to environmental harm, including danger to birds and other wildlife.
A pollution reduction treaty expected to be finalized next month may effectively end DDT production, said Roberts, a professor of tropical public health at the Uniformed Services University of Health Sciences in Bethesda, Maryland.
Roberts is part of a group called the Save Children from Malaria Campaign, which includes the Competitive Enterprise Institute, a think tank, and other groups in Africa, India and England.
Environmental groups denied they were trying to immediately ban DDT.
"There is broad agreement that DDT should not be banned globally until we are absolutely convinced that the countries that are using it have affordable, effective alternatives," said Richard Liroff, director of the World Wildlife Fund's Alternatives to DDT Project.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Telemedicine's Transformative Role in PPE Distribution and Sterile Equipment Management
July 22nd 2025In an era defined by digital transformation and post-pandemic urgency, telemedicine has evolved beyond virtual visits to become a vital infrastructure for delivering personal protective equipment (PPE) and managing sterile supplies. By enabling real-time forecasting, remote quality control, and equitable distribution, telemedicine is revolutionizing how health care systems protect both patients and providers.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.